New England Journal of Medicine2020Open AccessHighly Cited

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

Muthiah Vaduganathan, Orly Vardeny, Thomas Michel et al.

2,163 citations2020Open Access — see publisher for license terms1 related compound

Research Article — Peer-Reviewed Source

Original research published by Vaduganathan et al. in New England Journal of Medicine. Redistributed under Open Access — see publisher for license terms. MedTech Research Group provides these references for informational purposes. We do not conduct original research. All studies are the work of their respective authors and institutions.

Abstract

RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hy...

Full Text

Full text is available at the publisher.

Read at Publisher
Article Details
DOI10.1056/nejmsr2005760
JournalNew England Journal of Medicine
Year2020
AuthorsMuthiah Vaduganathan, Orly Vardeny, Thomas Michel, John J.V. McMurray, Marc A. Pfeffer, Scott D. Solomon
LicenseOpen Access — see publisher for license terms
Citations2,163